These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7572659)

  • 1. Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure.
    Tsutamoto T; Hisanaga T; Fukai D; Wada A; Maeda Y; Maeda K; Kinoshita M
    Am J Cardiol; 1995 Oct; 76(11):803-8. PubMed ID: 7572659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure.
    Tsutsui T; Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Ohnishi M; Kinoshita M
    J Am Coll Cardiol; 2002 Mar; 39(6):957-62. PubMed ID: 11897436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic value of circulating soluble cell adhesion molecules in patients with chronic congestive heart failure.
    Yin WH; Chen JW; Jen HL; Chiang MC; Huang WP; Feng AN; Lin SJ; Young MS
    Eur J Heart Fail; 2003 Aug; 5(4):507-16. PubMed ID: 12921812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure.
    Tsutamoto T; Hisanaga T; Wada A; Maeda K; Ohnishi M; Fukai D; Mabuchi N; Sawaki M; Kinoshita M
    J Am Coll Cardiol; 1998 Feb; 31(2):391-8. PubMed ID: 9462584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure.
    Maeda K; Tsutamoto T; Wada A; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Sawaki M; Fujii M; Matsumoto T; Kinoshita M
    J Am Coll Cardiol; 2000 Nov; 36(5):1587-93. PubMed ID: 11079662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure.
    Pacher R; Stanek B; Hülsmann M; Koller-Strametz J; Berger R; Schuller M; Hartter E; Ogris E; Frey B; Heinz G; Maurer G
    J Am Coll Cardiol; 1996 Mar; 27(3):633-41. PubMed ID: 8606275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased plasma concentrations of endothelin in congestive heart failure in humans.
    Rodeheffer RJ; Lerman A; Heublein DM; Burnett JC
    Mayo Clin Proc; 1992 Aug; 67(8):719-24. PubMed ID: 1434909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin in human congestive heart failure.
    Wei CM; Lerman A; Rodeheffer RJ; McGregor CG; Brandt RR; Wright S; Heublein DM; Kao PC; Edwards WD; Burnett JC
    Circulation; 1994 Apr; 89(4):1580-6. PubMed ID: 8149524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).
    Frantz RP; Lowes BD; Grayburn PA; White M; Krause-Steinrauf H; Krishnan V; Uyeda L; Burnett JC;
    J Card Fail; 2007 Aug; 13(6):437-44. PubMed ID: 17675057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of levosimendan on flow-mediated vasodilation and soluble adhesion molecules in patients with advanced chronic heart failure.
    Parissis JT; Karavidas A; Bistola V; Arapi S; Paraskevaidis IA; Farmakis D; Korres D; Filippatos G; Matsakas E; Kremastinos DT
    Atherosclerosis; 2008 Mar; 197(1):278-82. PubMed ID: 17568589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma big endothelin-1 concentrations in congestive heart failure patients with or without systemic hypertension.
    Pacher R; Bergler-Klein J; Globits S; Teufelsbauer H; Schuller M; Krauter A; Ogris E; Rödler S; Wutte M; Hartter E
    Am J Cardiol; 1993 Jun; 71(15):1293-9. PubMed ID: 8498369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure.
    Kinugawa T; Kato M; Ogino K; Osaki S; Igawa O; Hisatome I; Shigemasa C
    J Card Fail; 2003 Aug; 9(4):318-24. PubMed ID: 13680553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients.
    Adlbrecht C; Hülsmann M; Strunk G; Berger R; Mörtl D; Struck J; Morgenthaler NG; Bergmann A; Jakowitsch J; Maurer G; Lang IM; Pacher R
    Eur J Heart Fail; 2009 Apr; 11(4):361-6. PubMed ID: 19190023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure.
    Isnard R; Pousset F; Trochu J; Chafirovskaïa O; Carayon A; Golmard J; Lechat P; Thomas D; Bouhour J; Komajda M
    Am J Cardiol; 2000 Aug; 86(4):417-21. PubMed ID: 10946035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
    Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF
    J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
    Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP
    Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of plasma endothelin-1 in patients with chronic heart failure.
    Pousset F; Isnard R; Lechat P; Kalotka H; Carayon A; Maistre G; Escolano S; Thomas D; Komajda M
    Eur Heart J; 1997 Feb; 18(2):254-8. PubMed ID: 9043842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between plasma levels of cardiac natriuretic peptides and soluble Fas: plasma soluble Fas as a prognostic predictor in patients with congestive heart failure.
    Tsutamoto T; Wada A; Maeda K; Mabuchi N; Hayashi M; Tsutsui T; Ohnishi M; Fujii M; Matsumoto T; Yamamoto T; Takayama T; Kinoshita M
    J Card Fail; 2001 Dec; 7(4):322-8. PubMed ID: 11782855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of exercise ventilation in clinical evaluation and risk stratification in patients with chronic heart failure.
    Jankowska EA; Pietruk-Kowalczyk J; Zymliński R; Witkowski T; Ponikowska B; Sebzda T; Rzeczuch K; Borodulin-Nadzieja L; Hańczycowa H; Banasiak W; Ponikowski P
    Kardiol Pol; 2003 Aug; 59(8):115-27; commentary 126-7. PubMed ID: 14560326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.